LexaGene Holdings Inc. Quarterly Selling and Marketing Expense in USD from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
LexaGene Holdings Inc. quarterly Selling and Marketing Expense history and growth rate from Q3 2021 to Q4 2022.
  • LexaGene Holdings Inc. Selling and Marketing Expense for the quarter ending November 30, 2022 was $167K, a 69.4% decline year-over-year.
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $167K -$380K -69.4% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 $196K -$393K -66.7% Jun 1, 2022 Aug 31, 2022 10-Q 2022-10-18
Q4 2021 $547K Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 $589K Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.